Embryology outcomes after oocyte vitrification with super-cooled slush nitrogen are similar to outcomes with conventional liquid nitrogen: a randomized controlled trial.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Elsevier for the American Society for Reproductive Medicine Country of Publication: United States NLM ID: 0372772 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-5653 (Electronic) Linking ISSN: 00150282 NLM ISO Abbreviation: Fertil Steril Subsets: MEDLINE
    • Publication Information:
      Publication: New York. NY : Elsevier for the American Society for Reproductive Medicine
      Original Publication: New York, Hoeber.
    • Subject Terms:
      Oocytes*; Cryopreservation/*methods ; Embryonic Development/*physiology ; Nitrogen/*chemistry; Adult ; Aneuploidy ; Embryonic Development/drug effects ; Female ; Humans ; Infant, Newborn ; Male ; Nitrogen/pharmacology ; Oocyte Donation ; Pregnancy ; Pregnancy Rate ; Vitrification ; Young Adult
    • Abstract:
      Objective: To determine whether the use of slush nitrogen (SN), a super-cooled form of nitrogen with a temperature from -207 to -210 °C, can improve oocyte survival after vitrification and warming compared with conventional liquid nitrogen (LN).
      Design: Randomized controlled trial.
      Setting: Academic-affiliated private practice.
      Patient(s): A total of 556 metaphase II oocytes from 32 oocyte donor cycles were included.
      Intervention(s): Donor oocytes were block randomized to undergo vitrification with either SN or LN. Vitrification was followed by warming, fertilization with donor sperm, embryo culture to the blastocyst stage, and preimplantation genetic testing for aneuploidy via trophectoderm biopsy with targeted next-generation sequencing.
      Main Outcome Measure(s): The primary outcome was oocyte survival after vitrification and warming. Secondary outcomes included rates of fertilization, usable blastocyst formation, and whole chromosome aneuploidy.
      Result(s): Half of the metaphase II oocytes (n = 278) were randomized to undergo vitrification with SN, whereas the other half (n = 278) were randomized to undergo vitrification with LN. There were no statistically significant differences noted in oocyte survival rate (85.3% vs. 86.3%), fertilization rate (84.0% vs. 80.0%), rate of usable blastocyst formation (54.3% vs. 55.7%), or rate of whole chromosome aneuploidy (9.4% vs. 11.7%) between the SN and LN arms, respectively.
      Conclusion(s): The implementation of an SN oocyte vitrification protocol resulted in similar embryology outcomes compared with LN. The use of SN did not lead to any demonstrable improvement in oocyte survival after vitrification and warming.
      Clinical Trial Registration Number: NCT04342364.
      (Copyright © 2021 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.)
    • Contributed Indexing:
      Keywords: Cryopreservation; embryology; fertility preservation; oocytes; vitrification
    • Molecular Sequence:
      ClinicalTrials.gov NCT04342364
    • Accession Number:
      N762921K75 (Nitrogen)
    • Publication Date:
      Date Created: 20211016 Date Completed: 20220223 Latest Revision: 20220223
    • Publication Date:
      20240829
    • Accession Number:
      10.1016/j.fertnstert.2021.08.043
    • Accession Number:
      34654569